Literature DB >> 33768159

Proteome-based pathology: the next frontier in precision medicine.

Michael H Roehrl1,2, Victor B Roehrl3, Julia Y Wang3.   

Abstract

Entities:  

Keywords:  autoimmunity; cancer; clinical trial; diagnostics; drug development; mass spectrometry; pathology; precision medicine; proteomics

Year:  2021        PMID： 33768159      PMCID： PMC7986930          DOI： 10.1080/23808993.2021.1854611

Source DB:  PubMed          Journal:  Expert Rev Precis Med Drug Dev        ISSN： 2380-8993


× No keyword cloud information.
  16 in total

1.  Human proteins with affinity for dermatan sulfate have the propensity to become autoantigens.

Authors:  Jung-hyun Rho; Wei Zhang; Mandakolathur Murali; Michael H A Roehrl; Julia Y Wang
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases.

Authors:  Qian Yang; Prashant Bavi; Julia Y Wang; Michael H Roehrl
Journal:  J Proteomics       Date:  2017-06-29       Impact factor: 4.044

Review 3.  Mass-spectrometric exploration of proteome structure and function.

Authors:  Ruedi Aebersold; Matthias Mann
Journal:  Nature       Date:  2016-09-15       Impact factor: 49.962

Review 4.  Protein identification strategies in MALDI imaging mass spectrometry: a brief review.

Authors:  Daniel J Ryan; Jeffrey M Spraggins; Richard M Caprioli
Journal:  Curr Opin Chem Biol       Date:  2018-11-23       Impact factor: 8.822

5.  Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing.

Authors:  Henry Rodriguez; Stephen R Pennington
Journal:  Cell       Date:  2018-04-19       Impact factor: 41.582

6.  Research on the Human Proteome Reaches a Major Milestone: >90% of Predicted Human Proteins Now Credibly Detected, According to the HUPO Human Proteome Project.

Authors:  Gilbert S Omenn; Lydie Lane; Christopher M Overall; Ileana M Cristea; Fernando J Corrales; Cecilia Lindskog; Young-Ki Paik; Jennifer E Van Eyk; Siqi Liu; Stephen R Pennington; Michael P Snyder; Mark S Baker; Nuno Bandeira; Ruedi Aebersold; Robert L Moritz; Eric W Deutsch
Journal:  J Proteome Res       Date:  2020-10-19       Impact factor: 4.466

7.  Glycoproteomic analysis of human lung adenocarcinomas using glycoarrays and tandem mass spectrometry: differential expression and glycosylation patterns of vimentin and fetuin A isoforms.

Authors:  Jung-Hyun Rho; Michael H A Roehrl; Julia Y Wang
Journal:  Protein J       Date:  2009-05       Impact factor: 2.371

Review 8.  The Case for Proteomics and Phospho-Proteomics in Personalized Cancer Medicine.

Authors:  Sophia Doll; Florian Gnad; Matthias Mann
Journal:  Proteomics Clin Appl       Date:  2019-03       Impact factor: 3.494

9.  Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal cancer.

Authors:  Atsushi Tanaka; Yihua Zhou; Jinru Shia; Fiona Ginty; Makiko Ogawa; David S Klimstra; Ronald C Hendrickson; Julia Y Wang; Michael H Roehrl
Journal:  Oncotarget       Date:  2020-02-25

10.  SCoPE-MS: mass spectrometry of single mammalian cells quantifies proteome heterogeneity during cell differentiation.

Authors:  Bogdan Budnik; Ezra Levy; Guillaume Harmange; Nikolai Slavov
Journal:  Genome Biol       Date:  2018-10-22       Impact factor: 13.583
View more
  5 in total

Review 1.  Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma.

Authors:  Revati Sharma; George Kannourakis; Prashanth Prithviraj; Nuzhat Ahmed
Journal:  Front Med (Lausanne)       Date:  2022-06-14

2.  Progress Identifying and Analyzing the Human Proteome: 2021 Metrics from the HUPO Human Proteome Project.

Authors:  Gilbert S Omenn; Lydie Lane; Christopher M Overall; Young-Ki Paik; Ileana M Cristea; Fernando J Corrales; Cecilia Lindskog; Susan Weintraub; Michael H A Roehrl; Siqi Liu; Nuno Bandeira; Sudhir Srivastava; Yu-Ju Chen; Ruedi Aebersold; Robert L Moritz; Eric W Deutsch
Journal:  J Proteome Res       Date:  2021-10-20       Impact factor: 5.370

Review 3.  Immunoaffinity Capillary Electrophoresis in the Era of Proteoforms, Liquid Biopsy and Preventive Medicine: A Potential Impact in the Diagnosis and Monitoring of Disease Progression.

Authors:  Norberto A Guzman; Daniel E Guzman
Journal:  Biomolecules       Date:  2021-10-01

Review 4.  Application of nanomaterials in proteomics-driven precision medicine.

Authors:  Yong Zhang; Haonan Yang; Yanbao Yu; Ying Zhang
Journal:  Theranostics       Date:  2022-03-06       Impact factor: 11.600

5.  dia-PASEF data analysis using FragPipe and DIA-NN for deep proteomics of low sample amounts.

Authors:  Vadim Demichev; Lukasz Szyrwiel; Fengchao Yu; Guo Ci Teo; George Rosenberger; Agathe Niewienda; Daniela Ludwig; Jens Decker; Stephanie Kaspar-Schoenefeld; Kathryn S Lilley; Michael Mülleder; Alexey I Nesvizhskii; Markus Ralser
Journal:  Nat Commun       Date:  2022-07-08       Impact factor: 17.694
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.